Causes of Infertility: AGE/BIOLOGICAL CLOCK
Causes of Infertility: AGE/BIOLOGICAL CLOCK
A woman is born with all the eggs she will ever have. After menstruation starts, a monthly process of using up numerous eggs continues until the menopause, when most of her eggs have been used up, and both ovulation and menstruation cease. When the number of eggs remaining in the ovaries falls below a certain threshold, ovarian function begins to wane rapidly over a 5 to 10-year period, referred to as the climacteric. With the onset of the climacteric, blood Follicle Stimulating Hormone (FSH) levels begin to rise, Inhibin B concentrations fall (both as measured on the third day of a spontaneous menstrual cycle), and growing ovarian resistance to gonadotropins (stimulation medications) develops. Simultaneously, symptoms such as hot flashes, vaginal dryness and emotional instability emerge and then progressively worsen, the closer the woman gets to the menopause.
While the age of onset of both the climacteric and the menopause is largely genetically determined (and may vary from woman to woman) other factors, such as exposure to environmental toxins, radiation, systemic and pelvic pathology or surgery that compromises ovarian blood flow, can influence the timing of both events. Most American women will enter the climacteric in their early to mid forties and enter the menopause around age 45 to 55.
Egg quality progressively declines after age 35 as a normal consequence of progressive aging, such that an ever increasing number of a woman’s egg quota will, upon fertilization, have an abnormal chromosome number and/or structure (i.e., aneuploidy). It is important to note that even in young women, over 60% of eggs are aneuploid. The incidence increases with advancing age, so that by age 40-42 years, the incidence is probably around 80% – rising to over 90% by age 44-45.
Many aneuploid embryos develop into blastocysts (embryos). Some of these even implant into the uterine lining. While most aneuploid embryos will usually miscarry early in the first trimester of pregnancy, a few continue to develop into viable fetuses, some of which proceed to a live birth and manifest as a birth defect such as Trisomy-21 (Down’s syndrome).
The increased prevalence of embryo aneuploidy with advancing age also serves to clarify why the incidence of “infertility,” miscarriage, and chromosomal birth defects increases as women get older, and why infertility treatment becomes less effective.
The misconception that a raised FSH level is a cause of “poor embryo quality” stems from the observation that both commonly occur together during the climacteric. The young women who prematurely enter the climacteric commonly produce “good quality eggs and embryos” at IVF, (albeit that the number of both is likely to be low). Conversely, older women (e.g., in their mid-40s) with normal FSH and inhibin B levels routinely yield surprisingly large number of eggs/embryos, however these remain highly susceptible to quality-related deficiencies. Simply stated, it is age and not ovarian reserve that influences “egg/embryo quality.”
Related Posts
There are many different autoimmune implantation dysfunction associated with a variety of antibodies. Those most commonly associated with reproductive failure are: Antiphospholipid Antibodies (APA) Antithyroid Antibodies (ATA/AMA) Activated Natural Killer Cells (NKa) Antiphospholipid Antibodies (APA) Women who experience repeated IVF failures often have increased levels of circulating APAs-proteins that occur as small negatively charged structures on … Read more
ICSI involves the direct injection of a single sperm into each egg under direct microscopic vision. The successful performance of ICSI requires a high level of technical expertise. In centers of excellence, when ICSI is employed, the IVF birth rate is unaffected by the presence and severity of male infertility. In fact, even when there … Read more
GESTATIONAL SURROGACY With gestational surrogacy, one or more embryos derived from the patient’s eggs and her partner’s sperm is transferred into the uterus of a surrogate. The surrogate in effect provides a host womb but does not contribute genetically. In spite of original ethical, moral, and medical legal reservations, gestational surrogacy has now gained widespread … Read more
Indications Selecting an Egg Donor Matching the Egg Donor with the Recipient Egg Donor Recruitment Evaluating Prospective Egg Donor Candidates Preparation for the Egg Donor IVF Process The Cycle of Treatment Indications 1. Advancing age (beyond 40 years) is by far the most common reason why American women elect to work with an egg donor. … Read more
For an ever-increasing number of infertile women, ovarian failure is an insurmountable obstacle to the production of viable eggs. Yet the desire to achieve and carry a healthy pregnancy remains strong. Ovum donation (OD) – commonly called egg donation – provides them with a realistic opportunity of going from infertility to parenthood. Egg donation has … Read more
Gonadotropin Releasing Hormone Agonists (GnRHa) (Lupron, Buserelin, Nafarelin, Synarel) How does the GnRHa work? A GnRHa is a medication with a very similar in structure to the hormone called gonadotropin releasing hormone (GnRH). As such, its initial effect, for approximately 4-6 days, is to stimulate the pituitary gland to produce both LH and … Read more
On the third day of a spontaneous or progesterone withdrawal menstruation, blood is drawn to measure Estradiol (E2), FSH, LH and Inhibin-B. The specimen of blood should be sent to Millenova Immunology Laboratories in Chicago by overnight mail for the performance of the Inhibin-B test. Blood should also be drawn (any time) for the measurement … Read more
Ask Our DoctorsA Question
